These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 32825652)

  • 1. In Vitro Effect of Pitavastatin and Its Synergistic Activity with Isavuconazole against
    Hahn HJ; Escrig JI; Shing B; Debnath A
    Pathogens; 2020 Aug; 9(9):. PubMed ID: 32825652
    [No Abstract]   [Full Text] [Related]  

  • 2. The Antifungal Drug Isavuconazole Is both Amebicidal and Cysticidal against Acanthamoeba castellanii.
    Shing B; Singh S; Podust LM; McKerrow JH; Debnath A
    Antimicrob Agents Chemother; 2020 Apr; 64(5):. PubMed ID: 32094126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro activity of isavuconazole against three species of Acanthamoeba.
    Brunet K; Eestermans R; Rodier MH; Cateau E
    J Fr Ophtalmol; 2020 Apr; 43(4):330-333. PubMed ID: 32151474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Domain-Swap Dimerization of
    Sharma V; Shing B; Hernandez-Alvarez L; Debnath A; Podust LM
    Mol Pharmacol; 2020 Dec; 98(6):770-780. PubMed ID: 33008918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of Amebicidal and Cysticidal Activities of Antifungal Drug Isavuconazonium Sulfate against
    Shing B; Balen M; Debnath A
    Pharmaceuticals (Basel); 2021 Dec; 14(12):. PubMed ID: 34959694
    [No Abstract]   [Full Text] [Related]  

  • 6. HMG-CoA Reductase Inhibitors as Drug Leads against
    Hahn HJ; Abagyan R; Podust LM; Roy S; Ali IKM; Debnath A
    ACS Chem Neurosci; 2020 Oct; 11(19):3089-3096. PubMed ID: 32881478
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Miltefosine and polyhexamethylene biguanide: a new drug combination for the treatment of Acanthamoeba keratitis.
    Polat ZA; Walochnik J; Obwaller A; Vural A; Dursun A; Arici MK
    Clin Exp Ophthalmol; 2014 Mar; 42(2):151-8. PubMed ID: 23601234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug resistance and Acanthamoeba keratitis: the quest for alternative antiprotozoal chemotherapy.
    Hay J; Kirkness CM; Seal DV; Wright P
    Eye (Lond); 1994; 8 ( Pt 5)():555-63. PubMed ID: 7835453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Failure of chemotherapy in the first reported cases of Acanthamoeba keratitis in Pakistan.
    Siddiqui R; Chaudhry T; Lakhundi S; Ahmad K; Khan NA
    Pathog Glob Health; 2014 Jan; 108(1):49-52. PubMed ID: 24548160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-Acanthamoeba synergistic effect of chlorhexidine and Garcinia mangostana extract or α-mangostin against Acanthamoeba triangularis trophozoite and cyst forms.
    Sangkanu S; Mitsuwan W; Mahabusarakam W; Jimoh TO; Wilairatana P; Girol AP; Verma AK; de Lourdes Pereira M; Rahmatullah M; Wiart C; Siyadatpanah A; Norouzi R; Mutombo PN; Nissapatorn V
    Sci Rep; 2021 Apr; 11(1):8053. PubMed ID: 33850179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Silver Nanoparticles as a Novel Potential Preventive Agent against Acanthamoeba Keratitis.
    Hendiger EB; Padzik M; Sifaoui I; Reyes-Batlle M; López-Arencibia A; Rizo-Liendo A; Bethencourt-Estrella CJ; Nicolás-Hernández DS; Chiboub O; Rodríguez-Expósito RL; Grodzik M; Pietruczuk-Padzik A; Stępień K; Olędzka G; Chomicz L; Piñero JE; Lorenzo-Morales J
    Pathogens; 2020 May; 9(5):. PubMed ID: 32380785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Azole Antifungal Agents To Treat the Human Pathogens Acanthamoeba castellanii and Acanthamoeba polyphaga through Inhibition of Sterol 14α-Demethylase (CYP51).
    Lamb DC; Warrilow AG; Rolley NJ; Parker JE; Nes WD; Smith SN; Kelly DE; Kelly SL
    Antimicrob Agents Chemother; 2015 Aug; 59(8):4707-13. PubMed ID: 26014948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of combined chlorhexidine gluconate and neosporin on experimental keratitis with two pathogenic strains of Acanthamoeba.
    Polat ZA; Vural A
    Parasitol Res; 2012 May; 110(5):1945-50. PubMed ID: 22160252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In Vitro Evaluation of Farnesyltransferase Inhibitor and its Effect in Combination with 3-Hydroxy-3-Methyl-Glutaryl-CoA Reductase Inhibitor against
    Hahn HJ; Debnath A
    Pathogens; 2020 Aug; 9(9):. PubMed ID: 32842691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterizing clinical isolates of Acanthamoeba castellanii with high resistance to polyhexamethylene biguanide in Taiwan.
    Huang FC; Shih MH; Chang KF; Huang JM; Shin JW; Lin WC
    J Microbiol Immunol Infect; 2017 Oct; 50(5):570-577. PubMed ID: 26698685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimicrobial action of biguanides on the viability of Acanthamoeba cysts and assessment of cell toxicity.
    Mafra CS; Carrijo-Carvalho LC; Chudzinski-Tavassi AM; Taguchi FM; Foronda AS; Carvalho FR; de Freitas D
    Invest Ophthalmol Vis Sci; 2013 Sep; 54(9):6363-72. PubMed ID: 23900604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential anti-acanthamoebic effects through inhibition of CYP51 by novel quinazolinones.
    Ahmed U; Ho KY; Simon SE; Saad SM; Ong SK; Anwar A; Tan KO; Sridewi N; Khan KM; Khan NA; Anwar A
    Acta Trop; 2022 Jul; 231():106440. PubMed ID: 35378058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Investigation of the in vitro effects of Melissa officinalis L., Mentha x piperita L. and Ocimum basilicum L. (Lamiaceae) essential oils on the cysts and trophozoites of Acanthamoeba castellani].
    Ergüden C; Özkoç S; Öztürk B; Bayram Delibaş S
    Mikrobiyol Bul; 2016 Oct; 50(4):569-579. PubMed ID: 28124962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The reculture technique: individualizing the treatment of Acanthamoeba keratitis.
    Wysenbeek YS; Blank-Porat D; Harizman N; Wygnanski-Jaffe T; Keller N; Avni I
    Cornea; 2000 Jul; 19(4):464-7. PubMed ID: 10928758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Establishment of an Acanthamoeba keratitis mouse model confirmed by amoebic DNA amplification.
    Kang H; Sohn HJ; Park AY; Ham AJ; Lee JH; Oh YH; Chwae YJ; Kim K; Park S; Yang H; Jung SY; Kim JH; Shin HJ
    Sci Rep; 2021 Feb; 11(1):4183. PubMed ID: 33603075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.